Skip to content

Prevalence of Long-term Dental Effects of Chemotherapy in Childhood Cancer Survivors Diagnosed With Cancer Before the Age of 10

Prevalence of Long-term Dental Effects of Chemotherapy in Childhood Cancer Survivors Diagnosed With Cancer Before the Age of 10

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06517927
Enrollment
142
Registered
2024-07-24
Start date
2024-05-03
Completion date
2026-05-03
Last updated
2024-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chemotherapy Effect, Childhood Cancer, Dental Caries, Malocclusion, Tooth Defect

Keywords

Childhood cancer survivors, Dental defect

Brief summary

To date, there are no methods for assessing the risk of oral developmental defects that could predict long-term adverse effects in childhood cancer survivors. Having such a method at our disposal would enable us to better assess the risk to develop those defects and will help us provide new prevention and treatment strategies to ensure a healthy oral development. The aims of this study are : * Assess the caries risk in childhood cancer survivors compared with a control group. * Assess the dental development defects risk in childhood cancer survivors compared with a control group.

Detailed description

This will be an international study comparing the Childhood Cancer Survivors (CCS) and a control group. A questionnaire will be provided to the patients to gather information. A standard of care dental examination will then take place in a dental office in the Cliniques Universitaires Saint-Luc. We also collect medical data to complete the files.

Interventions

DIAGNOSTIC_TESTClinical and radiographic dental examination

complete clinical oral examination + intra-oral and panoramic x-rays

Sponsors

Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Interventionnal study, cohort study

Eligibility

Sex/Gender
ALL
Age
12 Years to 36 Years
Healthy volunteers
No

Inclusion criteria

* age below 10 at cancer diagnosis (for the CCS group). * Chemotherapy must have been used to treat the patient (For the CCS group). * The patient is 12 years old or older at the time of the follow-up appointment of the present study

Exclusion criteria

* A patient who was diagnosed and treated after 10 years old. * Patient below 12 years old at time of study recruitment * Patients with syndrome or diseases that involve teeth impairment\* * Pregnant patient * Refusal or inaptitude to undergo dental and radiographic examination

Design outcomes

Primary

MeasureTime frameDescription
Assessment of the caries experience by using the Decay Missing Filled Teeth score (DMFT)Thoughout the entire study, approximately during 2 yearsAssess the impact of the chemotherapy agents on the risk of ulterior caries development

Secondary

MeasureTime frameDescription
Assessment of the prevalence of dental development defects (DDD)Thoughout the entire study, approximately during 2 yearsAssess the impact of the chemotherapy agents on the risk of ulterior dental development defect

Countries

Belgium

Contacts

Primary ContactArmand IRAKOZE
armand.irakoze@uclouvain.be027645741

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026